Brokerage firm Leerink Swann Downgrades its rating on Imprivata Inc(NYSE:IMPR). The shares have been rated Market Perform. Previously, the analysts had a Outperform rating on the shares. The rating by Leerink Swann was issued on Jul 14, 2016.
In a different note, On May 4, 2016, Leerink Swann said it Maintains its rating on Imprivata Inc. In the research note, the firm Raises the price-target to $13.00 per share. The shares have been rated ‘Outperform’ by the firm.
Imprivata Inc (IMPR) shares turned negative on Mondays trading session with the shares closing down -0.04 points or -0.21% at a volume of 5,68,924. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $19.08. The peak price level was also seen at $19.08 while the days lowest was $19. Finally the shares closed at $19.01. The 52-week high of the shares is $21.63 while the 52-week low is $9. According to the latest information available, the market cap of the company is $481 M.
Imprivata Inc(IMPR) last announced its earnings results on May 3, 2016 for Fiscal Year 2016 and Q1.Company reported revenue of $31.52M. Analysts had an estimated revenue of $29.29M. Earnings per share were $-0.21. Analysts had estimated an EPS of $-0.31.
Several Insider Transactions has been reported to the SEC. On Jul 13, 2016, Christopher A Shaw (SVP and General Manager) sold 12,000 shares at $14.51 per share price.Also, On May 6, 2016, Jeffrey Kalowski (Chief Financial Officer) sold 10,000 shares at $12.98 per share price.On Apr 29, 2016, Omar Hussain (President and CEO) sold 18,936 shares at $12.12 per share price, according to the Form-4 filing with the securities and exchange commission.
Imprivata Inc. is a provider of healthcare information technology) IT security solutions. The Company’s solutions provide authentication management access to patient information and communications technologies to the healthcare industry. Its solutions include Imprivata OneSign Imprivata Cortext and Imprivata Confirm ID. Imprivata OneSign is a suite of authentication and access management products which consists of three offerings: authentication management enterprise single sign-on and workflow automation. Imprivata Cortext is a cloud-supported communications platform that provides healthcare organizations with texting and messaging services. Imprivata Confirm ID is a software product for electronic prescribing of controlled substances (EPCS).